News About: R&D
Icure acquires approval of Phase 3 clinical trial of donepezil patches for the first time
Icure, a pharmaceutical R&D company owning the original technology of the Transdermal Drug Delivery System(TDDS) and having the largest market share in the donepezil market, acquired approval for the Phase 3 clinical ...
What is the current trend for ‘anticancer’ clinical pipelines?
Approaches for R&Ds, including Open Innovation, have never been more diversified over new drug candidates. Domestic pharmaceutical companies are also racing to strengthen their new drug pipelines to follow the trend.
...
R&D investments of listed pharmaceutical companies remain unchanged
R&D investments of listed pharmaceutical companies have remained unchanged.
According to the analysis result of 3rd quarter’s performance reports of KOSPI and KOSDAQ listed pharmaceutical companies in 2015, the ratio...
Will newly-joined domestic pharmaceutical companies be successful in DPP-4 diabetic treatment market?
The DPP-4 inhibitor diabetes treatment market, which has been occupied by Januvia and Trajenta, has recently been invaded by domestic pharmaceutical companies.
Handok has made progress in commercializing ambitiously ...
Emergence of Treatment for multiple sclerosis patients failed in treatment
Multiple sclerosis(MS) patients who failed in treatment have now found an alternative.
The Ministry of Health and Welfare decided to accept the health insurance benefit of Genzyme’s ‘Lemtrada(alemtuzumab)’ on relapsi...
Supported by Samsung, a new era with MERS vaccine has begun
The International Vaccine Institute(IVI, Director General Jerome Kim) will hold the ‘2015 Sinil-IVI Global Vaccine Forum: International MERS-CoV Symposium’ at Novotel Ambassador Gangnam on the 10th. In order to develo...
The R&D investment of the pharmaceutical industry has been heated up
R&D investment of pharmaceutical companies has been heating up. Large pharmaceutical companies, in particular, are leading the phenomenon. On the other hand, mid-sized pharmaceutical companies seem to have hard time i...
Korea ranked 2nd in stem cell treatment clinical trials in the world
It is known that Korea ranked the 2nd in the number of clinical trials for stem cell treatments.
National Institute of Food and Drug Safety Evaluation, the Ministry of Food and Drug Safety announced on the 7th that i...
A type B hemophiliac treatment acquired the selling approval after the launch of the Benefix 10 years ago
A competing product of the only type B hemophiliac treatment launched in Korea, Benefix, is expected to be launched.
It has been 10 years since the launch of Benefix.
On the 6th, the Ministry of Food and Drug Safety...
There were 33,540 pharmaceutical patents in Korea for the past 7 years
The Korea Health Industry Development Institute (KHIDI)recently released a report titled ‘Trend Analysis Regarding the Healthcare Industry Using Domestic Patent Information’publicize the domestic pharmaceutical patent...
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
30 | 31 | 1 | 2 | 3 | 4 | 5 |
6 | 7 | 8 | 9 | 10 | 11 | 12 |
13 | 14 | 15 | 16 | 17 | 18 | 19 |
20 | 21 | 22 | 23 | 24 | 25 | 26 |
27 | 28 | 29 | 30 | 1 | 2 | 3 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
